H. Feng, et al.
Phytochemistry175(2020)112363
5 μm, Shiseido, Tokyo, Japan). An Agilent 1100 series HPLC system
with a Capcell Pak MG II C18 column (4.6 mm × 250 mm, 5 μm,
Shiseido, Tokyo, Japan) was used for HPLC-DAD analysis. MPLC was
performed on a Buchi Sepacore system (Buchi Labortechnik AG,
Switzerland), and a column packed with C-18 bonded silica gel
(45–60 μm, YMC Co., Ltd., Kyoto, Japan). D101 macroporous resin
(Sinopharm Chemical Reagent Co., Ltd., Shanghai, China), silica gel
(100–200 mesh, 200–300 mesh, Qingdao Marine Chemical Co., Ltd.,
Qingdao, China), Sephadex LH-20 (GE Healthcare Bio-Sciences AB,
Uppsala, Sweden) and MCI-gel (CHP20P, 75–100 μm, Mitsubishi
Chemical Industries Co., Tokyo, Japan) were used for open column
chromatography (CC). GC-MS analysis was carried out on a Trace DSQ
gas chromatography-mass spectrometer (ThermoFisher Scientific,
Waltham, MA, USA) equipped with a HP-5 MS capillary column
(Hewlett Packard, 30 m × 0.25 mm, film thickness 0.25 μm).
subjected to silica gel CC eluted with EtOAc, EtOAc-MeOH (50:1 and
10:1), and EtOAc-MeOH-H2O (10:1:0.1, 6:1:0.2, and 4:1:0.4) to give 6
fractions (Frs. 7.1–7.6). Fraction 7.2 (346 mg) eluting with EtOAc-
MeOH (50:1) was separated by Sephadex LH-20 (MeOH), followed by
purification via preparative TLC (silica gel, EtOAc-MeOH-H2O, 10:2:1)
to give 12 (113 mg). Fraction 7.3 (970 mg) eluting with EtOAc-MeOH
(10:1:0.1) was separated by Sephadex LH-20 using PE-CH2Cl2-MeOH
(3:1:1) as the eluting solvent to give two subfractions. The subfraction
7.3.1 was further purified by semi-preparative HPLC (solvent: MeCN-
H2O, 33:67; flow rate: 8 mL/min) to give 1 (tR = 31.39 min; 33 mg), 2
(tR = 39.48 min; 17 mg), 3 (tR = 40.59 min; 20 mg) and 6
(tR = 37.31 min; 13 mg). Similarly, 4 (tR = 11.67 min; 20 mg) was
obtained from the subfraction 7.3.2. Fraction 7.4 (1.2 g) was separated
by Sephadex LH-20 (CH2Cl2-MeOH, 1:1) and semi-preparative HPLC
(solvent: MeCN-H2O, 40:60; flow rate:
8 mL/min) to give 5
(tR = 34.34 min; 101 mg) and 13 (tR = 36.64 min; 30 mg). Fraction 10
(30 g) was subjected to MCI-gel with aqueous methanol (10–90%) to
give 9 subfractions. Then the subfraction 10.8 eluting with MeOH-H2O
(20:80) was separated by a combination of Sephadex LH-20 (MeOH-
H2O, 1:1) and semi-preparative HPLC (solvent: MeCN-H2O, 18:82; flow
rate: 8 mL/min) to give 14 (tR = 19.99 min; 80 mg). The subfraction
10.9 eluting with MeOH-H2O (10:90) was separated by a combination
of Sephadex LH-20 (MeOH) and semi-preparative HPLC (solvent:
MeCN-H2O, 30:70; flow rate: 8 mL/min) to give 15 (tR = 34.31 min;
19 mg) and 16 (tR = 35.49 min; 15 mg).
4.2. Chemicals
Fetal bovine serum (1659859), pancreatin (1806021), and peni-
cillin-streptomycin (15140-122) were purchased from ThermoFisher
Scientific (San Jose, CA, USA). Dulbecco's Modified Eagle Medium
(DMEM, AC11223317), dimethyl sulfoxide (DMSO, 60313ES60), di-
thiothreitol (DTT, D47340), D-luciferin potassium salt (D37410), and 3-
(4,5-dimethylthyazol-2-yl)-2,5-diphenzyl-tetrazolium bromide (MTT,
M03593) were purchased from Yeasen Biotech Co., Ltd. (Shanghai,
China). T0070907 was purchased from Selleck (Shanghai, China). Tris
(hydroxymethyl)methyl aminomethane (Tris, 154563), coenzyme A
(SLBR2838V), and adenosine triphosphate (ATP, SLBR1590V) were
4.4.1. Ilexcornutoside A (1)
20
Colorless needles (MeOH-H2O, 1:1); mp 265.3–266.5 °C, [α]D
purchased
from
Sigma-Aldrich
(St
Louis,
MO,
USA).
-33.0 (c 0.05, MeOH); IR νmax (KBr) cm−1: 3370, 2947, 1750, 1652,
1563, 1369, 1073; 1H NMR (600 MHz, C5D5N) and 13C NMR (150 MHz,
Ethylenediaminetetraacetic acid (EDTA, AR, 20140522), NaHCO3 (AR,
F20090928) and MgSO4 (AR, 20150828) were obtained from
Sinopharm Chemical Reagent Co., Ltd. (Shanghai, China).
4.3. Plant material
4.4.2. Ilexcornutoside B (2)
20
Colorless needles (MeOH-H2O, 1:1); mp 271.5–273.2 °C, [α]D
Leaves of Ilex cornuta Lindl. & Paxton (Aquifoliaceae) were pur-
chased from Bozhou Medicinal Materials Market (Anhui, China) in
January (winter), 2011. The material was authenticated by Dr. Lihong
Wu, Institute of Chinese Materia Medica, Shanghai University of
Traditional Chinese Medicine. A voucher specimen (No. 20110113-7)
was deposited at the same Institute.
-41.7 (c 0.05, MeOH); IR νmax (KBr) cm−1: 3358, 2946, 1646, 1552,
1371, 1076; 1H NMR (600 MHz, C5D5N) and 13C NMR (150 MHz,
4.4.3. Ilexcornutoside C (3)
20
White amorphous powders; [α]D -30.0 (c 0.05, MeOH); IR νmax
4.4. Extraction and isolation
(KBr) cm−1: 3349, 2942, 1648, 1555, 1370, 1077; 1H NMR (600 MHz,
MS m/z 803 [M+Na]+; HR-ESI-MS m/z 798.4626 [M+NH4]+ (calcd.
for C41H68O14N, 798.4634).
Leaves of I. cornuta (180 kg) were extracted in triplicate with 2700 L
of 75% aqueous ethanol under reflux for 2.5 h at 80 °C. The alcoholic
extracts were combined, evaporated under reduced pressure, and
freeze-dried to give a crude extract powder (21.84 kg). A part of the
resulting extract (1.21 kg) was suspended in distilled water and sub-
jected to a D101 macroporous resin column eluted with an EtOH-H2O
gradient. The 60% EtOH eluent (171.4 g) was subjected to silica gel CC
eluted successively with petroleum ether (PE) (60–90 °C), PE-CH2Cl2
(1:1), CH2Cl2, CH2Cl2-MeOH (50:1, 25:1, 10:1, 6:1, 3:1 and 1:1) and
MeOH to give 10 fractions (Frs. 1–10). Compound 8 (50 mg) was di-
rectly obtained by precipitating from fraction 2 eluting with PE-CH2Cl2
(1:1). Fraction 5 (5.3 g) eluting with CH2Cl2-MeOH (50:1) was further
fractionated by MPLC with a gradient of MeOH-H2O (from 10:90 to
100:0) to give fractions 5.1–5.8. Compound 9 (15 mg) was obtained by
precipitating from fraction 5.8 (MeOH eluent). Fraction 6 (10.8 g)
eluting with CH2Cl2-MeOH (10:1) was fractionated by MPLC with a step
gradient elution of MeOH-H2O (from 10:90 to 100:0) to give fractions
6.1–6.8. Fraction 6.2 (eluting with MeOH-H2O, 60:40) was chromato-
graphed on Sephadex LH-20 (CH2Cl2-MeOH, 1:1), and then purified by
preparative TLC (silica gel, CH2Cl2-MeOH, 10:1) to give 10 (8 mg) and
11 (33 mg). Compound 7 (20 mg) was obtained as a precipitate from
fraction 6.7 (eluting with MeOH-H2O, 90:10). Fraction 7 (34.4 g) was
4.4.4. Ilexcornutoside D (4)
20
Colorless needles (MeOH-H2O, 1:1); mp 288.1–288.8 °C; [α]D
-43.0 (c 0.05, MeOH); IR νmax (KBr) cm−1: 3347, 2940, 1605, 1547,
1455, 1389, 1073; 1H NMR (600 MHz, C5D5N) and 13C NMR (150 MHz,
4.4.5. Ilexcornutoside E (5)
20
White amorphous powders; [α]D +11.7 (c 0.05, MeOH); IR νmax
(KBr) cm−1: 3372, 2946, 1753, 1370, 1173, 1060; 1H NMR (600 MHz,
for C41H64O14Na, 789.4396).
4.4.6. Ilexcornutoside F (6)
20
Colorless needles (MeOH-H2O, 1:1); mp 261.9–262.8 °C, [α]D
-32.3 (c 0.05, MeOH); IR νmax (KBr) cm−1: 3369, 2943, 1757, 1706,
1647, 1363, 1162, 1077; 1H NMR (600 MHz, C5D5N) and 13C NMR
7